PC20-01a

Main Content

Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors

Study #: PC20-01a

Study Status: Published

Presentation(s)

2022, Tandem (Poster)

Effect of autograft CD34+ dose on outcome in pediatric patients undergoing autologous hematopoietic stem cell transplant for central nervous system tumors.

Citation

Knight TE, Ahn KW, Hebert KM, Atshan R, Wall DA, Chiengthong K, Rotz SJ, Fraint E, Rangarajan HG, Auletta JJ, Sharma A, Kitko CL, Hashem H, Williams KM, Wirk B, Dvorak CC, Myers KC, Pulsipher MA, Warwick AB, Lalefar NR, Schultz KR, Qayed M, Broglie L, Eapen M, Yanik GA.

Transplantation and Cellular Therapy. 2023, Jun 01: 29(6): 29(6):380.e1-380.e9. doi: 10.1016/j.jtct.2023.03.024. Epub 2023, Mar 27. PMCID:PMC10247464.

PubMed

PMID: 36990222

Abstract